Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iqvia Holdings Inc (NY: IQV )

201.82 +4.22 (+2.14%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,887,846
Open 197.03
Bid (Size) 201.07 (1)
Ask (Size) 207.96 (1)
Prev. Close 197.60
Today's Range 196.33 - 203.02
52wk Range 187.62 - 261.73
Shares Outstanding 181,500,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
(IQV) - Analyzing IQVIA Hldgs's Short Interest
Via Benzinga
Elliott Investment Management Adds To Southwest, Western Digital, Etsy, Match Group; Trims BILL Holdings, Seadrill, BlackLine, NRG Energy In Q3
Elliott Investment Management was busy in the third quarter. According to a new 13-F filing with the SEC, the activist made several portfolio moves, with multiple new positions focused around travel... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory

Performance

YTD
-12.40%
-12.40%
1 Month
-4.67%
-4.67%
3 Month
-18.58%
-18.58%
6 Month
-10.98%
-10.98%
1 Year
-4.81%
-4.81%

More News

Read More
IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024
From IQVIA Holdings Inc.
Via Business Wire
Peering Into IQVIA Hldgs's Recent Short Interest
Via Benzinga
Looking Into IQVIA Hldgs's Recent Short Interest
Via Benzinga
Peeling Back The Layers: Exploring IQVIA Hldgs Through Analyst Insights
Via Benzinga
How Is The Market Feeling About IQVIA Hldgs?
Via Benzinga
IQVIA Reports Third-Quarter 2024 Results and Announces Investor Day
From IQVIA Holdings Inc.
Via Business Wire
IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024
From IQVIA Holdings Inc.
Via Business Wire
GSK, Pfizer Face Declining Respiratory Syncytial Virus Vaccine Sales Due To Narrow Age Recommendations
Via Benzinga
IQVIA Announces IQVIA AI Assistant, Powered by IQVIA Healthcare-grade AI™
From IQVIA
Via Business Wire
A Closer Look at 13 Analyst Recommendations For IQVIA Hldgs
Via Benzinga
(IQV) - Analyzing IQVIA Hldgs's Short Interest
Via Benzinga
Breaking Down IQVIA Hldgs: 12 Analysts Share Their Views
Via Benzinga
Four Stocks To Watch This Week - Tuesday, Oct. 01
Via Talk Markets
Is Viking Therapeutics Stock a Buy?
Via The Motley Fool
IQVIA AI Solution Receives 2024 Frost & Sullivan Global Customer Value Leadership Award
From IQVIA
Via Business Wire
Cloud Stocks: Salesforce Preps To Enter Veeva’s Territory
Via Talk Markets
Contract Research Giant IQVIA's Data Assets Are Biggest Differentiator, Provides Best Exposure To AI And Data Opportunities: Analyst
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence COVID-19
Looking Into IQVIA Hldgs's Recent Short Interest
Via Benzinga
IQVIA Hldgs Stock: A Deep Dive Into Analyst Perspectives (13 Ratings)
Via Benzinga
IQVIA CFO Ron Bruehlman to Speak at the Morgan Stanley Annual Global Healthcare Conference on September 4, 2024
From IQVIA Holdings Inc.
Via Business Wire
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence
Home Depot To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates
From FN Media Group LLC
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.